Eric Benevich
2015
In 2015, Eric Benevich earned a total compensation of $3.2M as Chief Commercial Officer at Neurocrine Biosciences.
Compensation breakdown
| Bonus | $109,300 |
|---|---|
| Option Awards | $1,648,200 |
| Salary | $218,532 |
| Stock Awards | $1,044,500 |
| Other | $221,961 |
| Total | $3,242,493 |
Benevich received $1.6M in option awards, accounting for 51% of the total pay in 2015.
Benevich also received $109.3K in bonus, $218.5K in salary, $1M in stock awards and $222K in other compensation.
Rankings
In 2015, Eric Benevich's compensation ranked 2,874th out of 13,638 executives tracked by ExecPay. In other words, Benevich earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,874 out of 13,638 | 79th |
Division Manufacturing | 1,017 out of 5,187 | 80th |
Major group Chemicals And Allied Products | 375 out of 1,857 | 80th |
Industry group Drugs | 292 out of 1,531 | 81st |
Industry Biological Products, Except Diagnostic Substances | 52 out of 260 | 80th |
Source: SEC filing on April 20, 2017.
Benevich's colleagues
We found four more compensation records of executives who worked with Eric Benevich at Neurocrine Biosciences in 2015.
News
Neurocrine Biosciences CEO Kevin Gorman's 2021 pay rises 1% to $14M
April 7, 2022
Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
April 9, 2021
Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M
April 9, 2020
Neurocrine Biosciences CEO Kevin Gorman's 2018 pay rises 14% to $8.6M
April 17, 2019